CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Accelerated Share Repurchase Program, Adjustment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Accelerated Share Repurchase Program, Adjustment of $8.96 million for the 12-month period ending 2013-12-28, per its 10-K filed 2014-02-25.
Discontinued › Shareholders' Equity
us-gaap:AcceleratedShareRepurchaseProgramAdjustment · last filed 2014-02-25
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for the quarter ending 2011-09-24 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for the quarter ending 2010-12-25 was $43.07M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for fiscal 2013 was $8.96M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for fiscal 2011 was -$14.14M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. accelerated share repurchase program, adjustment for fiscal 2010 was -$58.35M.
| Period end | Accelerated Share Repurchase Program, Adjustment 3 month | Accelerated Share Repurchase Program, Adjustment 6 month | Accelerated Share Repurchase Program, Adjustment 9 month | Accelerated Share Repurchase Program, Adjustment 12 month |
|---|---|---|---|---|
| 2013-12-28 | $8.96M 10-K · filed 2014-02-25 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | -$14.14M 10-K · filed 2014-02-25 | |
| 2011-09-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$14.14M 10-Q · filed 2011-11-02 | ||
| 2011-06-25 | -$14.14M 10-Q · filed 2011-08-03 | |||
| 2010-12-25 | $43.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$58.35M 10-K · filed 2013-02-27 | ||
| 2010-09-25 | -$101.42M 10-Q · filed 2011-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |